EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Progress in Antibody Epitope Prediction

Xincheng Zeng iD, Ganggang Bai, Chuance Sun, Buyong Ma iD

Antibodies · 08.08.2023 · 12 (3) · 52

DOI: 10.3390/antib12030052 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antibodies, online erschienen am 08.08.2023. Verfasst von Xincheng Zeng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center of Cell & Therapeutic Antibody (MOE), School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent progress in epitope prediction has shown promising results in the development of vaccines and therapeutics against various diseases. However, the overall accuracy and success rate need to be improved greatly to gain practical application significance, especially conformational epitope prediction. In this review, we examined the general features of antibody–antigen recognition, highlighting the conformation selection mechanism in flexible antibody–antigen binding. We recently highlighted the success and warning signs of antibody epitope predictions, including linear and conformation epitope predictions. While deep learning-based models gradually outperform traditional feature-based machine learning, sequence and structure features still provide insight into antibody–antigen recognition problems.

Schlagwörter

Stichwörter der Autor:innen

antibodyantibody designartificial intelligenceepitope

Autor:innen und Institutionen

  • Engineering Research Center of Cell & Therapeutic Antibody (MOE), School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.
  • Shanghai Digiwiser Biological, Inc., Shanghai 200131, China.

ORCID-Profile: Xincheng Zeng, Buyong Ma

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality
  • Natural Science Foundation of China
  • Shanghai municipal government science innovation

Zitieren

APA

Zeng, X., Bai, G., Sun, C., & Ma, B. (2023). Recent Progress in Antibody Epitope Prediction. Antibodies, 12(3), 52. https://doi.org/10.3390/antib12030052

Vancouver

Zeng X, Bai G, Sun C, Ma B. Recent Progress in Antibody Epitope Prediction. Antibodies. 2023;12(3):52. doi:10.3390/antib12030052

BibTeX
@article{Zeng2023,
  author = {Zeng, Xincheng and Bai, Ganggang and Sun, Chuance and Ma, Buyong},
  title = {Recent Progress in Antibody Epitope Prediction},
  journal = {Antibodies},
  year = {2023},
  volume = {12},
  number = {3},
  pages = {52},
  doi = {10.3390/antib12030052}
}
Kostenlos starten →